SLC3A2 and laryngeal carcinoma: Additionally, SLC3A2 was a target gene of ZEB1 in breast cancer chemoresistance, it maybe the chemotherapy of laryngeal carcinoma is associsated with the result of high SLC3A2 patients with longer survival.